Medinet Co. Ltd. | Income Statement

Fiscal year is October-September. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,110
1,844
1,674
1,909
1,704
998
Cost of Goods Sold (COGS) incl. D&A
1,085
1,018
1,001
1,049
935
668
Gross Income
1,026
826
673
861
769
330
SG&A Expense
1,904
2,233
2,415
2,542
2,571
3,031
EBIT
878
1,407
1,742
1,681
1,802
2,701
Unusual Expense
5
671
64
5
889
704
Non Operating Income/Expense
527
473
112
26
51
381
Interest Expense
7
7
20
13
19
12
Pretax Income
342
1,571
1,665
1,634
2,636
3,038
Income Tax
7
10
47
9
32
11
Consolidated Net Income
348
1,581
1,712
1,643
2,604
3,049
Net Income
348
1,581
1,712
1,643
2,604
3,049
Net Income After Extraordinaries
348
1,581
1,712
1,643
2,604
3,049
Net Income Available to Common
348
1,581
1,712
1,643
2,604
3,049
EPS (Basic)
4.32
17.94
19.28
18.01
27.24
26.77
Basic Shares Outstanding
81
88
89
91
96
114
EPS (Diluted)
4.32
17.94
19.28
18.01
27.24
26.77
Diluted Shares Outstanding
81
88
89
91
96
114
EBITDA
667
1,212
1,464
1,324
1,481
2,508
Non-Operating Interest Income
21
41
48
39
25
14

About Medinet Co.

View Profile
Address
Shin-Yokohama Square Building, 14/F
Yokohama Kanagawa 222
Japan
Employees -
Website http://www.medinet-inc.co.jp
Updated 07/08/2019
MEDINET Co., Ltd. engages in cell processing business. It offers solutions for regenerative medicine and cell therapy value chain through preclinical research, development, manufacturing and commercial launch. It operates through the Cell Processing and Regenerative Medical Products segments.